Poland, Oct. 7 -- Poland based Astellas Pharma Sp. z o.o. has secured contract from Centrum Onkologii im. Franciszka Lukaszczyka w Bydgoszczy for Antineoplastic agents - Delivery of medicinal products - ENZALUTAMIDUM. The value of the contract is worth 29104944 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....